Proof Point
Venture capital funding in bioscience-related startups reached $14.86 billion in 2015 from $10.01 billion in 2012, growing annually by 14.1%
U.S. Bioscience-Related Venture Capital Investments
2012 – 2015 (US$ billions)
Proof Point Findings
- Bioscience – Studies and technologies related to living things, including personalized and regenerative medicine
- Peak VC Investment – Venture capital funding in bioscience-related firms reached $14.86 billion in 2015 from $10.01 billion in 2012, an annual growth of 14.1%
- Most Funded Segments – Human biotechnology, medical therapeutics, and medical/health information technology companies received most (74%) venture capital funding between 2012 and 2015
- Key Growth Drivers – Include proliferation of biotech and health startups, increasing application of new technologies and processes in bioscience, and intensifying research and development in different segments of bioscience, including bioinformatics, pharmaceuticals, and medical devices
|
Accelerator |
|
|
Market Disruption |
|
|
Sector |
Healthcare/Health Sciences
|
|
Source |
|
|
Date Last Updated |
September 7, 2017
|
